Melatonin and Nitrones As Potential Therapeutic Agents for Stroke

Stroke is a disease of aging affecting millions of people worldwide, and recombinant tissue-type plasminogen activator (r-tPA) is the only treatment approved. However, r-tPA has a low therapeutic window and secondary effects which limit its beneficial outcome, urging thus the search for new more eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero, Alejandro, Ramos, Eva, Patiño, Paloma, Oset-Gasque, Maria J., López-Muñoz, Francisco, Marco-Contelles, José, Ayuso, María I., Alcázar, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120103/
https://www.ncbi.nlm.nih.gov/pubmed/27932976
http://dx.doi.org/10.3389/fnagi.2016.00281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120103/
https://www.ncbi.nlm.nih.gov/pubmed/27932976
http://dx.doi.org/10.3389/fnagi.2016.00281

Ejemplares similares